These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25135838)

  • 21. Living donor renal transplantation: recent developments and perspectives.
    Baid-Agrawal S; Frei UA
    Nat Clin Pract Nephrol; 2007 Jan; 3(1):31-41. PubMed ID: 17183260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
    Nalesnik MA; Woodle ES; Dimaio JM; Vasudev B; Teperman LW; Covington S; Taranto S; Gockerman JP; Shapiro R; Sharma V; Swinnen LJ; Yoshida A; Ison MG
    Am J Transplant; 2011 Jun; 11(6):1140-7. PubMed ID: 21645251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery.
    Carver BS; Zibari GB; McBride V; Venable DD; Eastham JA
    Transplantation; 1999 Jun; 67(11):1438-40. PubMed ID: 10385082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taking values seriously: Ethical challenges in organ donation and transplantation for critical care professionals.
    Aulisio MP; Devita M; Luebke D
    Crit Care Med; 2007 Feb; 35(2 Suppl):S95-101. PubMed ID: 17242610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplant tumor registry: donors with central nervous system tumors1.
    Kauffman HM; McBride MA; Cherikh WS; Spain PC; Delmonico FL
    Transplantation; 2002 Feb; 73(4):579-82. PubMed ID: 11889434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia.
    Taioli E; Mattucci DA; Palmieri S; Rizzato L; Caprio M; Costa AN
    Transplantation; 2007 Jan; 83(1):13-6. PubMed ID: 17220783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marginal organs: how far should we go?
    Heemann U
    Transpl Int; 2010 May; 23(5):463-4. PubMed ID: 20456110
    [No Abstract]   [Full Text] [Related]  

  • 29. Utilization of elderly donors in living related kidney transplantation.
    Sahin S; Manga Sahin G; Turkmen A; Sever MS
    Transplant Proc; 2006 Mar; 38(2):385-7. PubMed ID: 16549126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of renal transplantation.
    Callaghan CJ; Bradley JA
    Methods Mol Biol; 2006; 333():1-28. PubMed ID: 16790845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The UNOS OPTN Waiting List and Donor Registry: 1988-1996.
    Harper AM; Rosendale JD
    Clin Transpl; 1996; ():69-90. PubMed ID: 9286559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Canadian Organ Replacement Register.
    Walker SR; Parsons DA; Coplestons P; Fenton SS; Greig PD
    Clin Transpl; 1996; ():91-107. PubMed ID: 9286560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-related issues in hand transplantation.
    McDiarmid SV; Azari KK
    Hand Clin; 2011 Nov; 27(4):545-52, x-xi. PubMed ID: 22051395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living lobar lung transplantation.
    Bowdish ME; Barr ML
    Respir Care Clin N Am; 2004 Dec; 10(4):563-79. PubMed ID: 15585183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection.
    Bajaj NS; Watt C; Hadjiliadis D; Gillespie C; Haas AR; Pochettino A; Mendez J; Sterman DH; Schuchter LM; Christie JD; Lee JC; Ahya VN
    Transpl Int; 2010 Jul; 23(7):e26-31. PubMed ID: 20444242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The UNOS OPTN waiting list and donor registry.
    Harper AM; Rosendale JD; McBride MA; Cherikh WS; Ellison MD
    Clin Transpl; 1998; ():73-90. PubMed ID: 10503086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the donor pool: use of marginal donors for solid organ transplantation.
    Alexander JW; Zola JC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):1-19. PubMed ID: 8652891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.
    Buell JF; Gross T; Alloway RR; Trofe J; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):583-4. PubMed ID: 15848464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended criteria donors: the case for liver procurement in donors with a central nervous system malignancy.
    Detry O
    Liver Transpl; 2009 Jun; 15(6):670-1. PubMed ID: 19479814
    [No Abstract]   [Full Text] [Related]  

  • 40. Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm.
    Sommer W; Kühn C; Tudorache I; Avsar M; Gottlieb J; Boethig D; Haverich A; Warnecke G
    J Heart Lung Transplant; 2013 Nov; 32(11):1065-72. PubMed ID: 23953918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.